These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 34229108)
1. Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD). Penthala NR; Balasubramaniam M; Dachavaram SS; Morris EJ; Bhat-Nakshatri P; Ponder J; Jordan CT; Nakshatri H; Crooks PA Eur J Med Chem; 2021 Nov; 224():113675. PubMed ID: 34229108 [TBL] [Abstract][Full Text] [Related]
2. MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells. Janganati V; Ponder J; Balasubramaniam M; Bhat-Nakshatri P; Bar EE; Nakshatri H; Jordan CT; Crooks PA Eur J Med Chem; 2018 Sep; 157():562-581. PubMed ID: 30121494 [TBL] [Abstract][Full Text] [Related]
3. Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells. Bommagani S; Ponder J; Penthala NR; Janganati V; Jordan CT; Borrelli MJ; Crooks PA Eur J Med Chem; 2017 Aug; 136():393-405. PubMed ID: 28525840 [TBL] [Abstract][Full Text] [Related]
4. Succinamide derivatives of melampomagnolide B and their anti-cancer activities. Janganati V; Ponder J; Thakkar S; Jordan CT; Crooks PA Bioorg Med Chem; 2017 Jul; 25(14):3694-3705. PubMed ID: 28545815 [TBL] [Abstract][Full Text] [Related]
5. Anti-cancer activity of carbamate derivatives of melampomagnolide B. Janganati V; Penthala NR; Madadi NR; Chen Z; Crooks PA Bioorg Med Chem Lett; 2014 Aug; 24(15):3499-502. PubMed ID: 24928404 [TBL] [Abstract][Full Text] [Related]
6. Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia. Albayati ZAF; Janganati V; Chen Z; Ponder J; Breen PJ; Jordan CT; Crooks PA Bioorg Med Chem; 2017 Feb; 25(3):1235-1241. PubMed ID: 28049618 [TBL] [Abstract][Full Text] [Related]
7. Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells. Janganati V; Ponder J; Jordan CT; Borrelli MJ; Penthala NR; Crooks PA J Med Chem; 2015 Nov; 58(22):8896-906. PubMed ID: 26540463 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A. Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809 [TBL] [Abstract][Full Text] [Related]
9. Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis. Alwaseem H; Frisch BJ; Fasan R Bioorg Med Chem; 2018 Apr; 26(7):1365-1373. PubMed ID: 28826596 [TBL] [Abstract][Full Text] [Related]
10. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades. Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209 [TBL] [Abstract][Full Text] [Related]
11. Epoxymicheliolide, a novelguaiane-type sesquiterpene lactone, inhibits NF‑κB/COX‑2 signaling pathways by targeting leucine 281 and leucine 25 in IKKβ in renal cell carcinoma. Zhu J; Zhao J; Yu Z; Shrestha S; Song J; Liu W; Lan W; Xing J; Liu S; Chen C; Cao M; Sun X; Wang Q; Song X Int J Oncol; 2018 Sep; 53(3):987-1000. PubMed ID: 29956738 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of melampomagnolide B derivatives as potential anti-Triple Negative Breast Cancer agents. Chen T; Chen X; Liu L; Zhang Q; Ding Y Eur J Med Chem; 2024 Jan; 264():116024. PubMed ID: 38104376 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Inhibition Potential of Nimbin and its Analogs against NF-κB Subunits p50 and p65: A Molecular Docking and Molecular Dynamics Study. Khan A; Singh D; Waidha K; Sisodiya S; Gopinath P; Hussian S; Tanwar P; Katare DP Anticancer Agents Med Chem; 2024; 24(4):280-287. PubMed ID: 37694791 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity, and in vivo antitumor activity study of parthenolide semicarbazones and thiosemicarbazones. Jia X; Liu Q; Wang S; Zeng B; Du G; Zhang C; Li Y Bioorg Med Chem; 2020 Jul; 28(13):115557. PubMed ID: 32546298 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel Xie X; Tu J; You H; Hu B Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074 [TBL] [Abstract][Full Text] [Related]
18. Effect of natural and semi-synthetic cadinanes from Heterotheca inuloides on NF-κB, Nrf2 and STAT3 signaling pathways and evaluation of their in vitro cytotoxicity in human cancer cell lines. Egas V; Millán E; Collado JA; Ramírez-Apan T; Méndez-Cuesta CA; Muñoz E; Delgado G Bioorg Med Chem; 2017 Jun; 25(12):3135-3147. PubMed ID: 28410869 [TBL] [Abstract][Full Text] [Related]
19. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade. Zhao J; Zhang Q; Zou G; Gao G; Yue Q J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511 [TBL] [Abstract][Full Text] [Related]